1. Home
  2. PBLS vs FHB Comparison

PBLS vs FHB Comparison

Compare PBLS & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.58

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

N/A

Current Price

$24.97

Market Cap

3.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PBLS
FHB
Founded
2015
1858
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
2026
2016

Fundamental Metrics

Financial Performance
Metric
PBLS
FHB
Price
$28.58
$24.97
Analyst Decision
Strong Buy
Hold
Analyst Count
6
11
Target Price
★ $41.40
$29.00
AVG Volume (30 Days)
1.1M
★ 2.4M
Earning Date
11-17-2026
10-23-2026
Dividend Yield
N/A
★ 4.14%
EPS Growth
N/A
★ 22.91
EPS
N/A
★ 1.67
Revenue
N/A
★ $880,788,000.00
Revenue This Year
N/A
$6.32
Revenue Next Year
$300.17
$56.09
P/E Ratio
★ N/A
$15.49
Revenue Growth
N/A
★ 8.94
52 Week Low
$22.66
$23.26
52 Week High
$42.49
$30.58

Technical Indicators

Market Signals
Indicator
PBLS
FHB
Relative Strength Index (RSI) 49.52 46.03
Support Level $26.42 $24.19
Resistance Level $41.72 $25.42
Average True Range (ATR) 2.25 0.61
MACD 0.60 0.01
Stochastic Oscillator 71.30 7.47

Price Performance

Historical Comparison
PBLS
FHB

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

Share on Social Networks: